Clinical Trial Update: Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study measuring plasma and intracellular concentrations of raltegravir and etravirine given once daily in HIV-1 infected participants. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)
• etravirine (etravirine)

Snippet

Sponsor: Hospitales Universitarios Virgen del Rocío | Conditions: HIV-1 Infection, HIV Infections | Phase 4 | Status: COMPLETED